Editorial: Type 2 diabetes and cancer: clinical and molecular interactions

Editorial: Type 2 diabetes and cancer: clinical and molecular interactions

Bibliographic Details
Main Authors:	Mariachiara Santorsola, Michele Caraglia, Alessandro Ottaiano
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Medicine
Subjects:	diabetes genetics cancer p53 lung cancer glioma
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1345732/full

Similar Items

p53: From Fundamental Biology to Clinical Applications in Cancer
by: Maurizio Capuozzo, et al.
Published: (2022-09-01)

Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
by: Alessandro Ottaiano, et al.
Published: (2023-01-01)

Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
by: Alessandro Ottaiano, et al.
Published: (2021-08-01)

Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
by: Alessandro Ottaiano, et al.
Published: (2022-01-01)

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
by: Mariachiara Santorsola, et al.
Published: (2022-07-01)

Sera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer
by: Sauriasari R, et al.
Published: (2020-02-01)

Molecular understanding of lung cancers–A review
by: Chinnappan Ravinder Singh, et al.
Published: (2014-05-01)

Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53
by: Douglas W. Brown, et al.
Published: (2022-10-01)

P53 mRNA in- Situ Hybridization analysis and Immunohistochemical Expression in Lung Cancer: A Comparative Study.
by: Ban A. Abdul-Majeed
Published: (2010-10-01)

The role of SNPs in the management of cancer in the broader population
by: Kitchen-Smith, I
Published: (2020)

P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation
by: Kostas A. Papavassiliou, et al.
Published: (2024-02-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias
by: Mariachiara Santorsola, et al.
Published: (2022-10-01)

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer
by: Hasen Alhebshi, et al.
Published: (2021-12-01)

Expression of anti-apoptotic protein survivin and tumor suppressor p53 protein in patients with pulmonary carcinoma
by: Halasová E, et al.
Published: (2009-12-01)

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors
by: Maurizio Capuozzo, et al.
Published: (2023-11-01)

Microarray Analysis in a Cell Death Resistant Glioma Cell Line to Identify Signaling Pathways and Novel Genes Controlling Resistance and Malignancy
by: Janina Seznec, et al.
Published: (2011-06-01)

From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
by: Alessandro Ottaiano, et al.
Published: (2023-08-01)

Association of p53 Arg/Pro Polymorphism at Codon 72 with Risk of Breast Cancer in East Azerbaijani Women
by: MA Hossein Pour Feizi, et al.
Published: (2012-03-01)

Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal
by: Alessandro Ottaiano, et al.
Published: (2021-06-01)

Multifaceted Insights into Innovative Approaches to Treating Colorectal Cancer Metastasis: From Emerging Biological Factors to Radiomics
by: Alessandro Ottaiano, et al.
Published: (2023-09-01)

Editorial: Advances in wild type and mutant p53 research in cancer
by: Olga N. Hernández-de la Cruz, et al.
Published: (2022-11-01)

Integrated High Throughput Analysis Identifies GSK3 as a Crucial Determinant of p53-Mediated Apoptosis in Lung Cancer Cells
by: Yu Zhang, et al.
Published: (2017-06-01)

Deregulation of p53 and RB Transcriptional Control Leads to Overexpression of DNA Methyltransferases in Lung Cancer
by: Yen-An Tang, et al.
Published: (2014-06-01)

Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
by: Shengliang Zhang, et al.
Published: (2022-04-01)

Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization
by: Rachelle P. Mendoza, et al.
Published: (2024-01-01)

Good Cop, Bad Cop: Defining the Roles of Δ40p53 in Cancer and Aging
by: Luiza Steffens Reinhardt, et al.
Published: (2020-06-01)

p53 Isoforms and Their Implications in Cancer
by: Maximilian Vieler, et al.
Published: (2018-08-01)

Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent
by: Alessio Malacrida, et al.
Published: (2023-01-01)

p53 regulates the effects of DAPT on Rac1 activation and migration of non-small-cell lung cancer cells
by: Lei Liu, et al.
Published: (2023-03-01)

RPL32 Promotes Lung Cancer Progression by Facilitating p53 Degradation
by: Jiansheng Xie, et al.
Published: (2020-09-01)

p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas
by: L.M. Massoni Neto, et al.
Published: (2007-08-01)

Conserved Double Translation Initiation Site for Δ160p53 Protein Hints at Isoform’s Key Role in Mammalian Physiology
by: Maria José López-Iniesta, et al.
Published: (2022-12-01)

Identification of P53 Tumor Suppressor Gene Alterations in Human Glioma Using Sscp-Pcr Technique.
by: Nzar A. Ameen, et al.
Published: (2015-09-01)

Immunohitochemical expression of p53 in human colocrectal carcinoma
by: Sazan abdulwahab Mirza, et al.
Published: (2016-10-01)

IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression
by: Lina Alhaddad, et al.
Published: (2021-05-01)

TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
by: Cheng Xu, et al.
Published: (2021-11-01)

Emerging Roles of p53 Family Members in Glucose Metabolism
by: Yoko Itahana, et al.
Published: (2018-03-01)

Bevacizumab-Induced Tumor Vasculature Normalization and Sequential Chemotherapy in Colorectal Cancer: An Interesting and Still Open Question
by: Alessandro Ottaiano, et al.
Published: (2021-09-01)

Detection and Quantification of Tp53 and p53-Anti-p53 Autoantibody Immune Complex: Promising Biomarkers in Early Stage Lung Cancer Diagnosis
by: Keum-Soo Song, et al.
Published: (2022-02-01)